Drugs / Auto-HHPG-19K
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06254742 | Feb 2024 → Jul 2025 | chemotherapy-induced toxicity | Jiangsu HengRui Medicine Co., Ltd. | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Auto-HHPG-19K | “first cycle: Auto-HHPG-19K Injection or HHPG-19K Injection second cycle: HHPG-19K Injection or Auto-HHPG-19K Injection” NCT06254742 ↗ |